Какова цена за In Veritas Medical Diagnostics, Inc. (IVME)

Цена за In Veritas Medical Diagnostics, Inc. (IVME) Это $0.0007

Какова рыночная капитализация для In Veritas Medical Diagnostics, Inc. (IVME)

Рыночная капитализация для In Veritas Medical Diagnostics, Inc. (IVME) Это $42.26K

In Veritas Medical Diagnostics, Inc. (IVME) Дивидендная доходность

In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.

Год	Дивидендная доходность	Изменить
Недостаточно данных для указанных дат.

Год

Дивидендная доходность

Изменить

Недостаточно данных для указанных дат.

Компания	Дивидендная доходность	Страна
Clone Algo Technologies Inc. CATI.US	0.00%	US
Worldwide Webb Acquisition Corp. WWAC.US	0.00%	US
Gushen, Inc. GSHN.US	0.00%	CN
Apollo Strategic Growth Capital APSG.US	0.00%	US
Digital World Acquisition Corp. DWAC.US	0.00%	US

Компания

Дивидендная доходность

Страна